You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Patent Applications for DORZOLAMIDE HYDROCHLORIDE

✉ Email this page to a colleague

US Patent Applications for DORZOLAMIDE HYDROCHLORIDE

Subscribe to access the full database, or Get Started Free
US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
⤷ Get Started Free	⤷ Get Started Free	Method for determining physiological effects of hemoglobin	2002-01-31	Abandoned -- Failure to Respond to an Office Action	2008-08-04
⤷ Get Started Free	⤷ Get Started Free	COMBINED AGENTS FOR TREATMENT OF GLAUCOMA	2002-05-16	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2012-01-09
⤷ Get Started Free	⤷ Get Started Free	Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma	2001-11-05	Abandoned -- Failure to Respond to an Office Action	2004-04-02
>US Patent Application	>Patent No.	>Title	>Patent Filing Date	>Patent Application Status	>Status Updated

WIPO Patent Applications for DORZOLAMIDE HYDROCHLORIDE

Subscribe to access the full database, or Get Started Free
WIPO Patent Application	Title	Patent Filing Date
⤷ Get Started Free
⤷ Get Started Free
⤷ Get Started Free
>WIPO Patent Application	>Title	>Patent Filing Date

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.